Report Interpretation

Overview

This is a Q4'26 preview for Siemens. J.P. Morgan expects the positive year-to-date operating trends to continue, retains its Overweight rating and leaves its €345 December 2027 price target unchanged.

Core views

J.P. Morgan expects Siemens' Q4'26 results, due on 12 November, to confirm continued strength in its core industrial portfolio. Its central view combines sustained Smart Infrastructure demand from data centers and utilities, further recovery evidence in Digital Industries, another strong Mobility order quarter, and only immaterial incremental cost inflation after pricing actions taken year to date. The report considers the resulting underlying outlook positive into Q4 and FY27, while the scheduled Healthineers separation becomes increasingly actionable ahead of a December spin-out report and a February AGM approval vote. For Q4, J.P. Morgan forecasts industrial orders excluding Healthineers of €19.8bn versus €17.8bn Bloomberg consensus, industrial revenue excluding Healthineers of €16.2bn versus €15.9bn consensus, and industrial profit excluding Healthineers of €2.8bn, about 5% above consensus. Its higher order forecast is driven primarily by Mobility, where its estimate is roughly 35% above consensus. At group level, it forecasts €27.8bn of orders, €23.3bn of revenue, €3.8bn of industrial profit and a 16.7% industrial-profit margin; this implies 27% year-on-year orders growth, 9% revenue growth and 19% industrial-profit growth. Digital Industries is expected to show an improving demand backdrop after margin pressure from normalized demand and customer and distributor destocking. J.P. Morgan forecasts Q4 orders of about €5.7bn, sales of €5.5bn and approximately 8% organic sales growth, with book-to-bill above 1x. Software annual recurring revenue is expected to grow by more than 10%, within its normal range, which the report says should reduce concerns about the software business. The division's forecast margin is 19.2%, including about €45m of severance costs. Smart Infrastructure is projected to deliver €7.5bn of orders and €7.0bn of revenue, or about 11% organic growth, with a 20.2% margin including €22m of severance; the report attributes this to the still-strong data-center environment and associated infrastructure demand. Mobility is expected to produce a strong order outcome in the €6bn-€7bn range, with J.P. Morgan using €6.5bn. The institution cautions that this division is inherently volatile because large orders are lumpy. It forecasts Mobility sales of €3.6bn, about 11% organic growth, and an 8.9% margin. Across annual forecasts, only minor Q4 assumption changes were made: orders through EPS change by roughly plus or minus 1%, leaving FY26 and later estimates essentially unchanged. J.P. Morgan's FY26E and FY27E earnings-per-share forecasts are €11.73 and €14.12, respectively, versus Bloomberg consensus of €11.20 and €12.84. The longer-term thesis rests on portfolio simplification, exposure to automation, software, electrification and mobility, and a shift from structural change and investment toward execution, margin improvement, returns and cash generation. J.P. Morgan views Siemens' 67% Healthineers stake, valued at roughly €32bn, as the next major simplification step and notes the plan to return about 30% of Healthineers to Siemens shareholders in 2027. Its unchanged December 2027 target is built with a sum-of-the-parts framework using the market value of Siemens Energy, its MedTech team's fair-value view of Healthineers, a 10% holding-company discount and generally conservative multiples below peer averages. The report also states that its reverse-DCF and sum-of-the-parts methodology remains unchanged.

Analysis framework

J.P. Morgan combines discussions with Siemens, top-down data and peer read-across with divisional Q4 forecasts and comparisons with Bloomberg consensus. It then tests the outlook through orders, organic sales growth, margins and earnings forecasts, and values the group with reverse-DCF and sum-of-the-parts approaches that separately consider the major businesses and investments.

Methodology notes

• Valuation methodsSOTP (Sum-of-the-Parts) Valuation

  Sum-of-the-parts valuation

  J.P. Morgan values Siemens' businesses and investments separately, incorporates Siemens Energy's market value and Healthineers fair value, and then applies a 10% holding-company discount to derive its price target.

• Valuation methods

  Reverse-DCF

  The report says its reverse-DCF methodology is unchanged; this approach is used alongside the sum-of-the-parts analysis to assess the valuation implied by market expectations.

• Industry AnalysisVolume-price decomposition

  Orders, sales growth and margin analysis by division

  The report evaluates each major division through expected orders, organic sales growth, book-to-bill and margins to explain the group outlook.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Siemens (SIEGn.F, SIE GR)

  Primary covered company; expected to benefit from Smart Infrastructure demand, Digital Industries recovery and strong Mobility orders.

  Strengths

  Exposure to automation, software, electrification and mobility; projected Smart Infrastructure strength; portfolio simplification and Healthineers separation.

  Weaknesses

  Digital Industries has faced margin pressure from demand normalization and destocking; Mobility orders are volatile.

  Comparison

  J.P. Morgan is above Bloomberg consensus for Q4 industrial orders excluding Healthineers, profit, and several divisional forecasts.

  Risks

  A delayed Healthineers exit, value-destructive M&A, a slower Digital Industries recovery, or a lower valuation multiple following a shift in views on Germany could weigh on the shares.

Key data

• Q4'26 industrial orders excluding Healthineers€19.8bnJ.P. Morgan forecast versus €17.8bn Bloomberg consensus, or 11% above consensus.
• Q4'26 industrial profit excluding Healthineers€2.8bnAbout 5% above Bloomberg consensus.
• Digital Industries Q4'26 sales growthc.8% organicJ.P. Morgan forecasts €5.5bn of sales and a 19.2% margin.
• Smart Infrastructure Q4'26 orders€7.5bnSupported by data-center and associated infrastructure demand.
• Mobility Q4'26 orders€6.5bnThe report notes volatility from the lumpy nature of large contracts.
• FY27E Siemens defined EPS pre-PPA€14.12J.P. Morgan estimate versus €12.84 Bloomberg consensus, 10% above consensus.
• Healthineers stake67%, c.€32bn fair valueSiemens plans to return about 30% of Healthineers to its shareholders in 2027.

Impact & implications

J.P. Morgan argues that continued execution in the core divisions and progress on the Healthineers separation support a positive FY27 outlook. The target valuation reflects both operating improvement and portfolio simplification, while retaining a 10% holding-company discount and conservative asset multiples.

Risks

• A protracted Healthineers exit would be negative for the stock.
• Further acquisitions at high multiples, or disposals and partnerships that reduce value, could hurt value in the short term.
• A slower-than-expected Digital Industries recovery would matter materially because it is Siemens' flagship division.
• A material deterioration in perceptions of the German economy or stimulus plans could lower the valuation multiple because of the shares' correlation with the DAX.

What to watch

• Siemens' Q4'26 results on 12 November, particularly orders, Smart Infrastructure data-center demand, Digital Industries recovery and Mobility contracts.
• The Healthineers spin-out report expected in December and shareholder approval at the February AGM.
• Whether pricing actions continue to offset cost inflation.
• Evidence that Digital Industries software ARR grows by more than 10% and book-to-bill remains above 1x.